Medical Condition News

RSS

Major genome science study offers insights into cardiac electrical diseases

New knowledge about biological processes related to the heart's electrical activity has been gained through a major genome science study. The research had the largest sample size ever of a project of this type.

28 Jul 2018

$Researchers use magnetic surgical cement for spinal fractures and targeted drug delivery$

Researchers use magnetic surgical cement for spinal fractures and targeted drug delivery

Patients with spinal fractures caused by tumors or osteoporosis usually undergo a procedure called kyphoplasty, where the fracture is filled with surgical cement.

28 Jul 2018

New study aims to develop nucleoside therapy as treatment for mitochondrial depletion syndromes

Hundreds of types of mitochondrial disease affect up to 38 million people worldwide, yet there are very few effective treatments, forcing patients and doctors to rely on symptom management to battle the serious and potentially fatal genetic disorder that starves the body’s cells of energy.

27 Jul 2018

Tübingen University Hospital introduces its new Elekta Unity cancer treatment system

On July 25, the radiation oncology department at Tübingen University Hospital introduced its new Elekta Unity MR-linac, a groundbreaking cancer treatment system that integrates two critical but distinct technologies in a single platform: a state-of-the-art, high field wide bore 1.5 Tesla MR imaging system and a next-generation linear accelerator.

27 Jul 2018

Survey: Blood cancers still take longer time for diagnosis than other types of cancer

A survey of patients treated for cancer on the NHS in England shows that blood cancers are still taking longer to be diagnosed than other types of cancer.

27 Jul 2018

LYVE-1 protein on macrophages found to be key to artery health

Arteries such as the aorta actively transport oxygenated blood, nutrients and cells throughout the body to keep our tissues functioning normally. Damage to the arteries can result in life-threatening cardiovascular diseases.

27 Jul 2018

Study: Reducing systolic blood pressure lowers MCI, dementia risk

Lowering one's blood pressure is beneficial not only for the heart, but also for the mind. For the first time, researchers have proved that lowering systolic blood pressure to 120 mm Hg or less reduces the risk of mild cognitive impairment, which in turn, reduces one's risk of developing Alzheimer's disease or dementia.

27 Jul 2018

OHSU researchers discover disease in monkeys that mimics childhood neurodegenerative disorder

OHSU scientists have discovered a naturally occurring disease in monkeys that mimics a deadly childhood neurodegenerative disorder in people - a finding that holds promise for developing new gene therapies to treat Batten disease.

27 Jul 2018

Genetic factors may play a role in progression of liver injury in Caucasians with hepatitis B infection

A new study has shown that genetic variation may increase the risk of severe liver damage in Caucasians with chronic hepatitis B infection.

27 Jul 2018

Portfolio diet reduces risk factors for cardiovascular disease

University of Toronto researchers have found that the portfolio diet, a plant-based way of eating previously shown to lower cholesterol levels, reduces other risk factors for cardiovascular disease including blood pressure, triglycerides and inflammation.

27 Jul 2018

Diet-induced obesity synchronizes opposing liver fat metabolic processes in mice

Mice fed a fattening diet develop new liver circadian rhythms that impact the way fat is accumulated and simultaneously burned, according to a new study published in Cell by researchers in the Perelman School of Medicine at the University of Pennsylvania.

27 Jul 2018

Cannabis appears to have no effect on breathlessness during exercise in advanced COPD patients

Inhaled vaporized cannabis does not appear to improve or worsen exercise performance and activity-related breathlessness in patients with advanced chronic obstructive pulmonary disease, according to a randomized controlled trial published online in the Annals of the American Thoracic Society.

27 Jul 2018

Researchers investigate how nephrologists should discuss treatment options with older patients

Kidney specialists differ in their approaches to treatment decision-making with older patients with kidney failure, with many nephrologists not describing conservative management and some limiting patients' role in decision-making, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology

27 Jul 2018

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Alnylam’s patisiran receives positive opinion from CHMP for treating hATTR amyloidosis

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the Committee for Medicinal Products for Human Use has adopted a Positive Opinion recommending marketing authorization of patisiran for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy.

27 Jul 2018

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

UCSF Benioff Children's Hospital Oakland clinical researchers, in conjunction with other sickle cell centers and scientists at Emmaus Life Sciences, Inc., have demonstrated that therapy with L-Glutamine reduced the frequency of pain episodes in both pediatric and adult patients with sickle cell disease.

27 Jul 2018

Targeting mossy cells may offer new strategy for treating brain disorders

A small population of brain cells deep in a memory-making region of the brain controls the production of new neurons and may have a role in common brain disorders, according to a study from scientists at the University of North Carolina School of Medicine.

27 Jul 2018

Medical Condition News

Major genome science study offers insights into cardiac electrical diseases

Researchers use magnetic surgical cement for spinal fractures and targeted drug delivery

New study aims to develop nucleoside therapy as treatment for mitochondrial depletion syndromes

Tübingen University Hospital introduces its new Elekta Unity cancer treatment system

Survey: Blood cancers still take longer time for diagnosis than other types of cancer

LYVE-1 protein on macrophages found to be key to artery health

Study: Reducing systolic blood pressure lowers MCI, dementia risk

OHSU researchers discover disease in monkeys that mimics childhood neurodegenerative disorder

Genetic factors may play a role in progression of liver injury in Caucasians with hepatitis B infection

Portfolio diet reduces risk factors for cardiovascular disease

Diet-induced obesity synchronizes opposing liver fat metabolic processes in mice

Cannabis appears to have no effect on breathlessness during exercise in advanced COPD patients

Researchers investigate how nephrologists should discuss treatment options with older patients

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Alnylam’s patisiran receives positive opinion from CHMP for treating hATTR amyloidosis

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

Targeting mossy cells may offer new strategy for treating brain disorders

Newer version of ALS drug may effectively treat inherited form of the disease

Brain scan can help select the right Parkinson’s patients for clinical trials

DePuy Synthes introduces new CONCORDE LIFT Implant to treat patients with degenerative disc disease

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News